Literature DB >> 1373023

Expression of oligodendroglia and Schwann cell markers in human nervous system tumors. An immunomorphological study and western blot analysis.

K Schwechheimer1, P Gass, H H Berlet.   

Abstract

Sixty tumors of the central and peripheral nervous system and seven brain metastases of extracranial carcinomas were examined using the peroxidase-antiperoxidase method to study the expression of myelin basic protein (MBP), myelin-associated glycoprotein (MAG) and the HNK-1/Leu-7 epitope. The immunocytochemical findings were compared with and correlated to Western blot results. None of the tumor types, including oligodendrogliomas, neurinomas and neurofibromas, expressed MAG and MBP, whereas myelin sheaths and their remnants within the tumors yielded specific immunoreactions. In contrast, the HNK-1/Leu-7 antibodies labelled the majority of the tumors tested including oligodendrogliomas and Schwann cell tumors. As demonstrated by Western blot experiments the HNK-1/anti-Leu-7 antibodies exhibited positive reactions with diverse polypeptides both in tumors and in non-neoplastic brain tissue at positions not corresponding to MAG. This suggests that the epitope recognized by HNK-1/Leu-7 antibodies is shared by a variety of unrelated proteins in normal and neoplastic tissues. Our results strongly indicate the absence of detectable amounts of MBP and MAG in oligodendrogliomas and Schwann cell tumors. The immunomorphological and immunochemical findings clearly showed the wide distribution of the HNK-1 epitope within different tumor types of the central and peripheral nervous system. In conclusion, the data demonstrate that specific cell markers for human oligodendrogliomas and Schwann cell tumors are still lacking.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1373023     DOI: 10.1007/bf00296791

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  50 in total

1.  The isolation of nerve endings from brain: an electron-microscopic study of cell fragments derived by homogenization and centrifugation.

Authors:  E G GRAY; V P WHITTAKER
Journal:  J Anat       Date:  1962-01       Impact factor: 2.610

2.  Myelin-associated glycoprotein in neurogenic tumours of the skin: an immunohistological study using Leu-7 monoclonal antibody.

Authors:  J Smolle; G F Walter; H Kerl
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

3.  Anti-lymphocyte antibody Leu-7 (HNK-1) recognizes a constituent of neuroendocrine granule matrix.

Authors:  A S Tischler; H Mobtaker; K Mann; G Nunnemacher; W J Jason; Y Dayal; R A Delellis; L Adelman; H J Wolfe
Journal:  J Histochem Cytochem       Date:  1986-09       Impact factor: 2.479

4.  Myelination in rat brain: method of myelin isolation.

Authors:  W T Norton; S E Poduslo
Journal:  J Neurochem       Date:  1973-10       Impact factor: 5.372

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

7.  Myelin-associated glycoprotein (MAG) in oligodendrogliomas. An immunohistochemical study.

Authors:  J Szymaś; A Wajgt
Journal:  Neuropatol Pol       Date:  1985

8.  Recognition of myelin-associated glycoprotein by the monoclonal antibody HNK-1.

Authors:  R C McGarry; S L Helfand; R H Quarles; J C Roder
Journal:  Nature       Date:  1983 Nov 24-30       Impact factor: 49.962

9.  IgM in a human neuropathy related to paraproteinemia binds to a carbohydrate determinant in the myelin-associated glycoprotein and to a ganglioside.

Authors:  A A Ilyas; R H Quarles; T D MacIntosh; M J Dobersen; B D Trapp; M C Dalakas; R O Brady
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

10.  Myelin basic protein and P2 protein are not immunohistochemical markers for Schwann cell neoplasms. A comparative study using antisera to S-100, P2, and myelin basic proteins.

Authors:  H B Clark; J J Minesky; D Agrawal; H C Agrawal
Journal:  Am J Pathol       Date:  1985-10       Impact factor: 4.307

View more
  3 in total

1.  Proteomic identification of glutamine synthetase as a differential marker for oligodendrogliomas and astrocytomas.

Authors:  Zhengping Zhuang; Meng Qi; Jie Li; Hiroaki Okamoto; David S Xu; Rajiv R Iyer; Jie Lu; Chunzhang Yang; Robert J Weil; Alexander Vortmeyer; Russell R Lonser
Journal:  J Neurosurg       Date:  2011-06-17       Impact factor: 5.115

Review 2.  Pathology and molecular genetics of oligodendroglial tumors.

Authors:  Christian Hartmann; Wolf Mueller; Andreas von Deimling
Journal:  J Mol Med (Berl)       Date:  2004-10       Impact factor: 4.599

3.  Inhibition of myelin formation by HIV-1 gp120 in rat cerebral cortex culture.

Authors:  J Kimura-Kuroda; K Nagashima; K Yasui
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.